Kyberlife would like to announce the closure of our SEED investment round. Thank you to all who have believed in us, we will continue to work hard. We'd like to take a moment to introduce and welcome our closing investors.
Warm welcome to our closing investors
From left to right: Bernd Lepper, Maarten Kelder and Rebecca Ng
Kyberlife is excited to welcome Bernd Lepper, Maarten Kelder and Rebecca Ng as our closing SEED investors of Kyberlife.
With our partnership, they bring forward their expertise in healthcare, hospital/clinical management, and the pharmaceutical industry. We are committed to build stronger bonds and network with the healthcare and scientific community with their support.
We would also like to introduce Bernd Lepper as Kyberlife’s Board of Directors.
Bernd Lepper
Bernd Lepper is the Founder and CEO of Intega Healthcare offering market entry for quality prescription drugs, medical devices and consumer health products.
Prior to Intega Healthcare, Bernd was the Regional Vice President of Healthcare for DKSH (DiethelmKellerSiberHegner), and the General Manager Healthcare for DKSH.
Bernd also served as the Managing Director for Sanofi-Aventis Indonesia, CFO and GM for Aventis Pharma Thailand.
Maarten Kelder
Maarten Kelder was Zuellig Pharma’s former Executive Vice President of Strategy, M&A, Partnerships, Corporate Development and Digital Transformation. He drove company growth and transformation, as well as helping ZP to invest and collaborate with digital health start-ups.
Prior to Zuellig Pharma, Maarten was the Managing Director and Lead Partner at Monitor Deloitte.
Maarten also served on many boards such as MedAdvisor, Klinify, Galen Growth and China Polymetallic Mining.
Rebecca Ng
Rebecca Ng is the Co-Founder and Business Development & Operations Director of Intega Healthcare.
Prior to Intega Healthcare, Rebecca was the ASEAN Supply Chain Director at Smith & Newphew and the SEA Head of operations at Synthes.
Once again, thank you to all our investors and to all who believes in Kyberlife. We will continue to grow so stay tuned. Our series A investment round has opened, should you be interested, please do reach out and we look forward to hearing from you.